020 7713 0990

 

These guidelines provide guidance on the management of patients with AL amyloidosis.  The guideline discusses the principles of treating a patient with AL amyloidosis and provides recommendations and details for treatments (including stem cell transplantation) both at diagnosis and relapse.  Monitoring of treatment and definitions of response are discussed.  

These guidelines also make recommendations for supportive care.  

Declaration of Interests

The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request.